Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON)

CUSIP: 254604101

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 7 signals
Share change
+3,426,874
Put/Call ratio
22%
SEC-reported price per share
$63.94
Number of holders
201
Value change
+$184,842,370
Number of buys
119
Open additional details 1 more signal available
Number of sells
81
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
37,778,373

Security key

254604101

Report period

Q1 2026

Institutions

201

Top holders

10

Ownership snapshot

Top reported holders of IRON - Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
31 Dec 2025
13F 13D/G 3/4/5 Lead comparable stake: 14% 13D/G row: FMR LLC Showing 1-6 of 15 holder rows.

Quick read

FMR LLC leads the comparable SEC ownership view at 14%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.
Comparable ownership Top 5
FMR LLC 14%
AI DMI LLC 8%
RA CAPITAL MANAGEMENT, L.P. 5.9%
ORBIMED ADVISORS LLC 4.5%
WELLINGTON MANAGEMENT GROUP LLP 4.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
FMR LLC
13F 13D/G
Company
14%
from 13D/G
$432,802,132
5,450,222 shares
31 Dec 2025
AI DMI LLC
3/4/5 13D/G
10%+ Owner
8%
from 13D/G
$226,473,078
2,814,379 shares
-$59,873,462 22 Oct 2025
RA CAPITAL MANAGEMENT, L.P.
13D/G 13F
Company
5.9%
$177,001,530
2,228,924 shares
$0 30 Dec 2025
ORBIMED ADVISORS LLC
13F 13D/G 3/4/5
Company · Director
4.5%
from 13D/G
$84,774,146
1,067,550 shares
31 Dec 2025
WELLINGTON MANAGEMENT GROUP LLP
13F 13D/G
Company
4.1%
from 13D/G
$120,566,138
1,518,274 shares
31 Dec 2025
Paradigm Biocapital Advisors LP
13D/G
3.5%
$57,097,283
1,210,971 shares
$0 31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
201
Shares
41,790,891
Rows available
201
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q1 2026 Across Filers

Q1 2026 holders
201
Q1 2026 holders
201
Holder diff
0
Investor Q1 2026 Shares Q1 2026 Shares Share Diff Share Chg % Q1 2026 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .